Chemoprevention Completed Phase 1 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0044244 (Chemoprevention)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00955149Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)Prevention